School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Aquestive Therapeutics Inc AQST

Healthcare · Pharmaceuticals

$4.80last close 2026-10-12 · market cap $599.95M · delayed data

Trailing returns

1M+0.42%
3M+16.50%
6M+17.65%
1Y-26.61%
5Y+27.32%

Basis: Adjusted daily closes.

What it does

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron…

Open AQST in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies